weakly significantP = 0.033
However, when we assessed HOMA-IR variations during treatment on the basis of different kinetics of viral load decay, we found a significant reduction of HOMA-IR values at week 12 and a still but weakly significant reduction at week 48 from baseline in the EVR ( P = 0.033 and 0.048, resp.) but not in the non-EVR groups ( Table 4 ).